Since its emergence 25 years ago, group B streptococcus has become recognized as a
cause of serious illness in newborns, pregnant women, and adults with chronic medical …

During the 1980s, investigation of several large epidemics of listeriosis confirmed that
transmission of L. monocytogenes in food causes human disease. Progress in laboratory …

Background Group B streptococcal infections are a leading cause of neonatal mortality, and
they also affect pregnant women and the elderly. Many cases of the disease in newborns …

WHO Research and Development Blueprint Scientific Advisory Group that met on March 2,
2020, in Geneva, Switzerland, to prioritise the recommendations of an earlier meeting on …

Background Before the introduction of the conjugate vaccines, Haemophilus influenzae
type b was the major cause of bacterial meningitis in the United States, and meningitis was …

Background In early 2000, a protein–polysaccharide conjugate vaccine targeting seven
pneumococcal serotypes was licensed in the United States for use in young children. Methods …

During the 1990s the focus of group B streptococcus (GBS) disease research has shifted to
prevention. Increased use of intrapartum antimicrobial prophylaxis in North America and …

The United States is in the midst of an opioid overdose epidemic. Between 1999 and 2010,
prescription opioid–related overdose deaths increased substantially in parallel with …

Group B streptococcus (GBS) remains a leading cause of serious neonatal infection despite
great progress in perinatal GBS disease prevention in the 1990s. In 1996, CDC, in …

Background Guidelines issued in 1996 in the United States recommend either screening of
pregnant women for group B streptococcal colonization by means of cultures (screening …